Outcome After Conservative and Endovascular Treatment of Stanford Type B Aortic Intramural Hematomas - A Single-Center Retrospective Study.

Heiner NebelungRalf-Thorsten HoffmannVerena PlodeckMarvin KapallaBianca BohmannAlbert BuschNorbert WeissChristian ReepsSteffen Wolk

Published in: Vascular and endovascular surgery (2023)

Prognosis of IMH seems favourable in both surgically as well as conservatively treated patients. However, it is essential to identify patients at high risk for complications under conservative treatment, who therefore should be treated by TEVAR. In our study, ULPs seem to be an adverse factor for remodeling.

Keyphrases

newly diagnosed
end stage renal disease
ejection fraction
endovascular treatment
prognostic factors
risk factors
coronary artery
aortic dissection
combination therapy
electronic health record
adverse drug